Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

Grab it low when you can.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
heartofachild Member Profile
Member Level 
Followed By 4
Posts 62
Boards Moderated 0
Alias Born 01/09/19
160x600 placeholder
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 7/10/2020 10:26:14 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 7/9/2020 2:56:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/6/2020 5:16:05 PM
Therapeutic Solutions International Universal Donor Immunotherapy StemVacs™ Activates Antiviral Immune Cells InvestorsHub NewsWire - 6/30/2020 9:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 6/30/2020 6:23:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:42:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:36:40 PM
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy InvestorsHub NewsWire - 6/22/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:17:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:14:11 PM
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway InvestorsHub NewsWire - 6/15/2020 7:06:21 AM
Therapeutic Solutions International Issues "NOT US" Notice to Shareholders InvestorsHub NewsWire - 6/14/2020 8:10:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:26:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:23:57 PM
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer New InvestorsHub NewsWire - 6/11/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 1:46:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2020 1:29:30 PM
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™ InvestorsHub NewsWire - 6/8/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 12:14:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 12:10:19 PM
Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement InvestorsHub NewsWire - 6/4/2020 9:00:00 AM
San Diego Top Doctor Collaborates with Therapeutic Solutions International to Report QuadraMune™ Immune Boosting Data InvestorsHub NewsWire - 6/1/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/29/2020 4:31:25 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 5/28/2020 3:09:04 PM
Annual Report (10-k) Edgar (US Regulatory) - 5/21/2020 1:26:17 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist